Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.

Durrani K, Zakka FR, Ahmed M, Memon M, Siddique SS, Foster CS. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease. Surv Ophthalmol. 2011 Nov-Dec; 56(6):474-510.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.